top of page

DATA ANALYSIS FOR BIOTECH & PHARMA

Uncover signals in complex data.

Even from small, heterogeneous cohorts.

Ariana combines explainable AI and scientific expertise to uncover meaningful relationships in your data, especially in Phase I and Phase II programmes with small, heterogeneous cohorts.

We identifies explainable relationships across your complex datasets, helping your team investigate combinations of factors associated with an outcome. 

Additional 
indications
Surrogate biomarkers 
Mechanistic understanding
Safety signals
Optimal sequences
Best responder
profiles
Optimal combinations
Dose and exposure

Questions we can explore with your data

Our data scientists work with you to interpret the findings, complement your existing analyses, and turn promising signals into hypotheses to investigate.

Responder
profiles
Safety signals
Responder
profiles
Treatment combinations
Responder
profiles
Biomarker discovery

Neuroscience

Anavex

Exploring clinical and molecular features associated with treatment response in an early Alzheimer’s disease study.

Oncology

argenX

Investigating response patterns in a 17-patient study of ARGX-111.

argenX

Case Studies 

Ophthalmology

Fovea

Characterising patient subgroups associated with response in allergic conjunctivitis.

Experience across therapeutic areas

Oncology
Neurology
Immunology
Rare Disease
Gene & Cell Therapy
Ophthalmology
Inflammatory diseases
and more...
bottom of page